Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: p27 suppresses cyclooxygenase-2 expression by inhibiting p38β and p38δ-mediated CREB phosphorylation upon arsenite exposure.

Authors: Che, Xun; Liu, Jinyi; Huang, Haishan; Mi, Xiaoyi; Xia, Qing; Li, Jingxia; Zhang, Dongyun; Ke, Qingdong; Gao, Jimin; Huang, Chuanshu

Published In Biochim Biophys Acta, (2013 Sep)

Abstract: p27 is a cyclin-dependent kinase (CDK) inhibitor that suppresses a cell's transition from G0 to S phase, therefore acting as a tumor suppressor. Our most recent studies demonstrate that upon arsenite exposure, p27 suppresses Hsp27 and Hsp70 expressions through the JNK2/c-Jun- and HSF-1-dependent pathways, suggesting a novel molecular mechanism underlying the tumor suppressive function of p27 in a CDK-independent manner. We found that p27-deficiency (p27-/-) resulted in the elevation of cyclooxygenase-2 (COX-2) expression at transcriptional level, whereas the introduction of p27 brought back COX-2 expression to a level similar to that of p27+/+ cells, suggesting that p27 exhibits an inhibitory effect on COX-2 expression. Further studies identified that p27 inhibition of COX-2 expression was specifically due to phosphorylation of transcription factor cAMP response element binding (CREB) phosphorylation mediated by p38β and p38δ. These results demonstrate a novel mechanism underlying tumor suppression effect of p27 and will contribute to the understanding of the overall mechanism of p27 tumor suppression in a CDK-independent manner.

PubMed ID: 23639288 Exiting the NIEHS site

MeSH Terms: Animals; Arsenites/pharmacology*; Cell Line; Cyclic AMP Response Element-Binding Protein/genetics; Cyclic AMP Response Element-Binding Protein/metabolism*; Cyclin-Dependent Kinase Inhibitor p27/genetics; Cyclin-Dependent Kinase Inhibitor p27/metabolism*; Cyclooxygenase 2/biosynthesis*; Cyclooxygenase 2/genetics; Gene Expression Regulation, Enzymologic/drug effects*; Gene Expression Regulation, Enzymologic/genetics; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 11/genetics; Mitogen-Activated Protein Kinase 11/metabolism*; Mitogen-Activated Protein Kinase 13/genetics; Mitogen-Activated Protein Kinase 13/metabolism*; Phosphorylation/drug effects; Phosphorylation/genetics; Teratogens/pharmacology*; Transcription, Genetic/drug effects; Transcription, Genetic/genetics

to Top